Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E M Roth

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of Chronic Diseases|February 1, 1973
Viral-host relationships in chronic diseases of manE M Roth, R C Williams
Behaviour|January 1, 1971
The effects of acute crowding on aggressive behavior of Japanese monkeysB K Alexander, E M Roth
Ergonomics|October 11, 1992
Cognitive simulation as a tool for cognitive task analysisE M Roth, D D Woods, H E Pople
Human Factors|August 5, 2000
There is more to monitoring a nuclear power plant than meets the eyeR J Mumaw, E M Roth, K J Vicente, et al.
Journal of Thrombosis and Thrombolysis|June 22, 1999
Efficacy of abciximab induced platelet blockade using a rapid point of care assayD J Kereiakes, M Mueller, W Howard, et al.
American Heart Journal|January 29, 2000
Platelet glycoprotein IIb/IIIa receptor blockers: An appropriate-use model for expediting care in acute coronary syndromesD J Kereiakes, M McDonald, T Broderick, et al.
The American Journal of Cardiology|September 1, 1999
Time course, magnitude, and consistency of platelet inhibition by abciximab, tirofiban, or eptifibatide in patients with unstable angina pectoris undergoing percutaneous coronary interventionD J Kereiakes, T M Broderick, E M Roth, et al.
Journal of Thrombosis and Thrombolysis|December 30, 1999
High platelet count in platelet-rich plasma reduces measured platelet inhibition by abciximab but not tirofiban nor eptifibatide glycoprotein IIb/IIIa receptor antagonistsD J Kereiakes, T M Broderick, E M Roth, et al.
The Journal of Invasive Cardiology|April 14, 2000
Combination enoxaparin-abciximab therapy during coronary intervention: the next standard of care?D A Tramuta, D J Kereiakes, E J Dippel, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 14, 2001
Coronary perforation during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade: an algorithm for percutaneous managementE J Dippel, D J Kereiakes, D A Tramuta, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Chronic Diseases|February 1, 1973
Viral-host relationships in chronic diseases of manE M Roth, R C Williams
Behaviour|January 1, 1971
The effects of acute crowding on aggressive behavior of Japanese monkeysB K Alexander, E M Roth
Ergonomics|October 11, 1992
Cognitive simulation as a tool for cognitive task analysisE M Roth, D D Woods, H E Pople
Human Factors|August 5, 2000
There is more to monitoring a nuclear power plant than meets the eyeR J Mumaw, E M Roth, K J Vicente, et al.
Journal of Thrombosis and Thrombolysis|June 22, 1999
Efficacy of abciximab induced platelet blockade using a rapid point of care assayD J Kereiakes, M Mueller, W Howard, et al.
American Heart Journal|January 29, 2000
Platelet glycoprotein IIb/IIIa receptor blockers: An appropriate-use model for expediting care in acute coronary syndromesD J Kereiakes, M McDonald, T Broderick, et al.
The American Journal of Cardiology|September 1, 1999
Time course, magnitude, and consistency of platelet inhibition by abciximab, tirofiban, or eptifibatide in patients with unstable angina pectoris undergoing percutaneous coronary interventionD J Kereiakes, T M Broderick, E M Roth, et al.
Journal of Thrombosis and Thrombolysis|December 30, 1999
High platelet count in platelet-rich plasma reduces measured platelet inhibition by abciximab but not tirofiban nor eptifibatide glycoprotein IIb/IIIa receptor antagonistsD J Kereiakes, T M Broderick, E M Roth, et al.
The Journal of Invasive Cardiology|April 14, 2000
Combination enoxaparin-abciximab therapy during coronary intervention: the next standard of care?D A Tramuta, D J Kereiakes, E J Dippel, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 14, 2001
Coronary perforation during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade: an algorithm for percutaneous managementE J Dippel, D J Kereiakes, D A Tramuta, et al.
Pageof 2